According to the latest report by IMARC Group, titled “Digital PCR Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028,” offers a comprehensive analysis of the industry, which comprises insights on the global digital PCR market share. The report also includes competitor and regional analysis, and contemporary advancements in the market.
The global digital PCR market size reached US$ 4.3 Billion in 2022. Looking forward, IMARC Group expects the market to reach a value of US$ 7.9 Billion on by 2028, exhibiting a growth rate (CAGR) of 10.5%% during 2023-2028
Digital polymerase chain reaction, or digital PCR (dPCR), represents an end-point, high-throughput absolute quantitative analytics that aids in measuring the DNA or RNA count of a given sample in a precise and sensitive way. Compared to its traditional counterparts, digital PCR uses a wide range of methods, such as droplet-based, chip-based, and beaming dPCR, to facilitate diverse applications. As a result, digital PCR methods are extensively used in basic and diagnostic research, including human genetic testing, pathogen detection, and forensic sciences.
Request For Sample Report: https://www.imarcgroup.com/digital-pcr-market/requestsample
Industry Trends & Drivers
The increasing healthcare expenditure on molecular diagnosis across the globe, on account of the growing prevalence of numerous diseases, including genetic disorders, COVID-19, lung cancer, brain tumors, etc., is among the key elements stimulating the digital PCR market. Moreover, the escalating demand for early diagnosis and treatment has resulted in extensive R&D that focuses on genetic technologies, which is acting as another significant growth-inducing factor.
Besides this, continuous technological advancements in PCR technologies and the development of innovative devices for droplet, chip-based, beam, and crystal dPCR by major market players are positively influencing the global market. Furthermore, the widespread adoption of dPCR devices in reference laboratories for detecting genetic mutations and identifying pathogens is also propelling the market growth. Apart from this, the launch of favorable initiatives undertaken by governmental and federal agencies across the globe, the shifting preferences from plant-derived to genome-based drug discovery, and the rising applications of these devices in food microbiology and veterinary medicine are anticipated to fuel the digital PCR market over the forecasted period.
The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.
Avance Biosciences Inc., Bio-Rad Laboratories Inc., Danaher Corporation, JN Medsys, OPTOLANE Technologies Inc., QIAGEN, SAGA Diagnostics AB, Standard BioTools Inc., Stilla Technologies, Sysmex Corporation and Thermo Fisher Scientific Inc.
The report has been segmented the market into following categories:
Breakup by Product Type:
- Digital PCR Equipment
- Consumables and Reagents
- Software and Services
Breakup by Technology:
- Droplet Digital PCR
- BEAMing Digital PCR
Breakup by Application:
- Clinical Diagnostics
- Asia Pacific
- North America
- Middle East and Africa
- Latin America
On the geographical front, Asia Pacific enjoys the leading position in the market. This can be attributed to the rising establishment of international companies in the region, on account of low manufacturing costs and cheap labor.
Ask An Analyst: https://www.imarcgroup.com/request?type=report&id=5897&flag=C
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
IMARC Services Private Limited.
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 |
Africa and Europe :- +44-702-409-7331 |
Asia: +91-120-433-0800, +91-120-433-0800